ABSTRACT
Although rare, primary chondrosarcoma is the most frequent malignant tumor of the sternum. It commonly manifests as a painful, expanding mass arising from the costochondrosternal junction. Since it is resistant to radiotherapy and chemotherapy, surgical resection with reconstruction is the preferred treatment. A 50-year-old male presented with swelling over the left fourth sternocostal joint, gradually increasing in size. Imaging and clinical assessment suggested an infiltrative neoplasm, and surgical resection was indicated. The patient underwent a partial sternectomy, including a resection of the xiphoid process and costal cartilages two to seven and a partial resection of the manubrium. Postoperative pathohistological analysis specified the change as a low-grade chondrosarcoma in the pT1 stage. Chest wall reconstruction involved three pectus bars fixated around the ribs and the placement of a synthetic polypropylene mesh. The patient required postoperative rehospitalization due to partial skin layer wound dehiscence, serous drainage, and fever. Empirical antibiotic therapy was initiated, and the patient underwent a median superior laparotomy with partial omentoplasty of the sternal region, preserving the mesh and pectus bars. A culture analysis revealed methicillin-resistant Staphylococcus epidermidis, and postoperative antibiotic therapy was adapted to the antibiogram. Subsequently, all parameters of inflammation decreased, and wound healing followed. A one-year follow-up CT scan showed no disease recurrence. This case highlights the intricate surgical management that contributed to the successful treatment of sternal chondrosarcoma. Sternal wound infection, a severe postoperative complication with a high mortality rate, requires prompt identification, precise revision with culture-directed antibiotics, and effort to preserve the prosthetic material.
ABSTRACT
Pulmonary hyalinizing granuloma (PHG) is an unusual benign pulmonary disease with nonspecific symptoms and slow progression, characterized by solitary or multiple fibrosing nodules. A definitive diagnosis of PHG usually requires a wide excisional biopsy. Associations of PHG with lymphoproliferative disorders, such as Castleman's disease and lymphoma, have been described. PHG is considered a paraneoplastic manifestation of those diseases. Treatment in most cases comprises therapy of the underlying condition with or without the use of empirical corticosteroid therapy. We report a case of a 57-year-old Caucasian female, who presented initially with dyspnea, fatigue, dry mouth, difficulty swallowing, night sweats, weight loss, and recurrent sinusitis. A physical examination revealed hepatosplenomegaly with generalized lymphadenomegaly. Chest computed tomography showed bilateral diffuse nodular changes about 10 mm in diameter in the lung parenchyma. A needle biopsy of a lymph node confirmed the diagnosis of non-Hodgkin lymphoma and chemotherapy was started. Since the parenchymal lung lesions progressed and no definite diagnosis could be made on the basis of transbronchial biopsy, a right-sided video-assisted thoracoscopy with atypical resection of the abnormalities was performed. The findings were consistent with a diagnosis of pulmonary hyalinizing granuloma. Due to preserved pulmonary function, there was no indication for starting corticosteroid therapy. The purpose of this case report is to draw attention to the possibility of pulmonary hyalinizing granuloma as a differential diagnosis when multiple nodular lesions are observed in the lungs. Although PHG is a rare entity, due to its frequent association with underlying diseases and nonspecific presentation, a careful investigation should be performed. For a definite diagnosis, a surgical biopsy is required.
